The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
99181913 9918191 3 F 20130321 20140216 20140223 20160815 EXP US-MERCK-1303USA012908 MERCK 52.00 YR F Y 53.52000 KG 20160815 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
99181913 9918191 1 PS MK-2206 INVESTIGATIONAL PRODUCT 1 Oral 135 MG, QW 1620 MG 0 135 MG TABLET /wk
99181913 9918191 2 SS PACLITAXEL. PACLITAXEL 1 Intravenous (not otherwise specified) 133 MG, QW 1596 MG 0 133 MG INJECTION /wk
99181913 9918191 3 SS TRASTUZUMAB TRASTUZUMAB 1 Intravenous (not otherwise specified) 236 MG, QW 2832 MG 0 236 MG INJECTION /wk
99181913 9918191 4 SS DOXORUBICIN DOXORUBICIN 1 Intravenous (not otherwise specified) 98 MG, QOW 72.93 MG 0 98 MG INJECTION QOW
99181913 9918191 5 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) 980 MG, QOW 729.302 MG 0 980 MG INJECTION QOW
99181913 9918191 6 C PEGFILGRASTIM PEGFILGRASTIM 1 Subcutaneous 6MG/0.6ML, QW U 0 /wk
99181913 9918191 7 C ONDANSETRON ONDANSETRON 1 Oral 8 MG, PRN U 0 8 MG
99181913 9918191 8 C ONDANSETRON ONDANSETRON 1 U 0
99181913 9918191 9 C PROCHLORPERAZINE MALEATE. PROCHLORPERAZINE MALEATE 1 Oral 10 MG, PRN U 0 10 MG
99181913 9918191 10 C PROCHLORPERAZINE MALEATE. PROCHLORPERAZINE MALEATE 1 U 0
99181913 9918191 11 C DOCUSATE SODIUM. DOCUSATE SODIUM 1 Oral 250 MG, PRN U 0 250 MG
99181913 9918191 12 C SENNOSIDES. SENNOSIDES 1 Oral 8.6 MG, PRN U 0 8.6 MG
99181913 9918191 13 C DEXAMETHASONE. DEXAMETHASONE 1 Intravenous (not otherwise specified) 20 MG/50 ML, PRN 12675 INJECTION
99181913 9918191 14 SS CIPROFLOXACIN. CIPROFLOXACIN 1 Oral 500 MG, BID 0 500 MG BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
99181913 9918191 1 Breast cancer
99181913 9918191 6 Neutropenia
99181913 9918191 7 Vomiting
99181913 9918191 8 Nausea
99181913 9918191 9 Nausea
99181913 9918191 10 Vomiting
99181913 9918191 11 Constipation
99181913 9918191 12 Constipation
99181913 9918191 14 Antibiotic therapy

Outcome of event

Event ID CASEID OUTC COD
99181913 9918191 OT
99181913 9918191 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
99181913 9918191 Enterocolitis infectious
99181913 9918191 Febrile neutropenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
99181913 9918191 1 20121217 20130307 0
99181913 9918191 2 20121217 20130307 0
99181913 9918191 3 20121217 20130307 0
99181913 9918191 4 20130314 20130425 0
99181913 9918191 5 20130314 20130425 0
99181913 9918191 6 20130315 20130426 0
99181913 9918191 7 20130314 0
99181913 9918191 9 20130314 0
99181913 9918191 14 20130505 20130510 0